ADVFN - Advanced Financial Network.
HOME» NASDAQ » M » MYL Stock Price » MYL Stock News

Mylan Inc. Share News

 Mylan Inc. (mm) Stock Price
MYL Stock Price
 Mylan Inc. (mm) Stock Chart
MYL Stock Chart
 Mylan Inc. (mm) Stock News
MYL Stock News
 Mylan Inc. (mm) Company Information
MYL Company Information
 Mylan Inc. (mm) Stock Trades
MYL Stock Trades

Mylan Confirms Endo Suit Over Generic Migraine Drug Application

DOW JONES NEWSWIRES Mylan Inc. (MYL) confirmed Wednesday that it has been sued by Endo Pharmaceuticals Holdings Inc. (ENDP) over its application for approval of a generic drug used to treat acute migraine headaches in adults. Mylan--one of the world's largest generic drug makers--said it believes it is the first company to file a substantially complete application for approval of frovatriptan succinate EQ, a generic version of Frova. The company said it expects to qualify for 180 days of marketing exclusivity upon final approval from the Food and Drug Administration. Mylan, which has had litigation-related charges figure prominently in its recent quarterly results, last month reported second-quarter earnings surged 70% as sales got a lift from a weaker dollar. Shares closed Tuesday at $20.01 and were inactive in recent premarket trade. Through the latest close, the stock is down 5.3% since the start of the year. -By Mia Lamar, Dow Jones Newswires; 212-416-3207; mia.lamar@dowjones.com

Stock News for Mylan Inc. (MYL)
DateTimeHeadline
12/01/201617:06:35Securities Registration: Business Combination (s-4)
12/01/201617:06:35Securities Registration: Business Combination (s-4)
12/01/201613:34:00The Law Offices of Howard G. Smith Announces the Filing of a...
12/01/201609:37:00Mylan's Commitment to Stemming the Tide of HIV/AIDS as Strong...
11/29/201617:02:28Current Report Filing (8-k)
11/28/201607:30:00Mylan Signs Sub-license Agreement with the Medicines Patent Pool...
11/25/201611:34:00SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors...
11/18/201623:45:00DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching...
11/18/201622:07:00MYLAN SHAREHOLDER ALERT by Former Louisiana Attorney General:...
11/14/201606:16:45Current Report Filing (8-k)
11/09/201617:50:00Mylan Posts Loss, Hurt by Lower EpiPen Volumes, Charge Related...
11/09/201617:26:39Quarterly Report (10-q)
11/09/201616:15:44Current Report Filing (8-k)
11/09/201616:05:00Mylan Reports Third Quarter 2016 Results
11/09/201610:30:00INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation...
11/08/201607:30:00Mylan and Biocon Announce U.S. FDA Submission for Proposed Biosimilar...
11/04/201622:07:00MYLAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL:...
11/03/201618:51:00Glancy Prongay & Murray LLP Commences Investigation on Behalf...
11/03/201618:10:00Generic-Drug Makers' Shares Drop on Report of Possible Probe
11/03/201616:08:00DOJ Looking Into Possible Price Collusion in Generic Drug Sector...

Mylan Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US